Global Porcine Vaccines

Porcine Vaccines Comprehensive Study by Type (Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines), Application (Swine Fever Vaccines, Swine Flu Vaccines, Porcine Circoviruses, Others) Players and Region - Global Market Outlook to 2026

Porcine Vaccines Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Porcine Vaccines Market Overview:
Porcine Vaccines refer to a clinical as well as an administrative drug that ameliorates swine health by protecting them from a variety of bacteria, viruses and other pathogens. Increasing pork consumption, the growing prevalence of various swine diseases, and rising per capita animal healthcare expenditure are the factors that are expected to grow in the market.

Growth Drivers
  • Rise in Investments by Governments in the Field of Animal Health Care
  • High Incidence of Swine Fever

Market Trends
  • Increase in R&D Expenses Incurred for Eradicating Porcine Health Issues

Roadblocks
  • High Expenses of Maintaining and Handling Storage Conditions

Opportunities
  • Surge in the Demand for Porcine Meat and Gelatin
  • Technological Advancements such as Combined Vaccine Production and DNA Vaccines

Challenges
  • Chance of Reverse Reaction from Vaccines


Competitive Landscape:
There are various companies that are exploring the footprint in new geographical regions by adopting various market growth strategies including mergers & acquisitions, expansions, investments, new solution launches, and others. The market key players are capturing market growth opportunities by rapidly investing in research and development initiatives.
Some of the key players profiled in the report are Bayer AG (Germany), Bimeda, Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Ceva Sante Animale (France), Eli Lilly and Company (United States), Merck & Co., Inc. (United States), Sanofi S.A. (France), Vetoquinol S.A. (France) and Zoetis, Inc. (United States). Additionally, following companies can also be profiled that are part of our coverage like PBS Animal Health (United States) and Aptimmune (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Porcine Vaccines market by 2026.

What Can be Explored with the Porcine Vaccines Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Porcine Vaccines Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Porcine Vaccines
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Porcine Vaccines market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Porcine Vaccines market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Porcine vaccines manufacturers, Porcine vaccines suppliers, Private research laboratories, Research and development (R&D) companies, Market research and consulting service providers, Government research laboratories and Contract manufacturing organizations.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Inactivated vaccines
  • Live attenuated vaccines
  • Toxoid vaccines
  • Recombinant vaccines
  • Conjugate vaccines
  • DNA vaccines
By Application
  • Swine Fever Vaccines
  • Swine Flu Vaccines
  • Porcine Circoviruses
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Investments by Governments in the Field of Animal Health Care
      • 3.2.2. High Incidence of Swine Fever
    • 3.3. Market Challenges
      • 3.3.1. Chance of Reverse Reaction from Vaccines
    • 3.4. Market Trends
      • 3.4.1. Increase in R&D Expenses Incurred for Eradicating Porcine Health Issues
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Porcine Vaccines, by Type, Application and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Porcine Vaccines (Value)
      • 5.2.1. Global Porcine Vaccines by: Type (Value)
        • 5.2.1.1. Inactivated vaccines
        • 5.2.1.2. Live attenuated vaccines
        • 5.2.1.3. Toxoid vaccines
        • 5.2.1.4. Recombinant vaccines
        • 5.2.1.5. Conjugate vaccines
        • 5.2.1.6. DNA vaccines
      • 5.2.2. Global Porcine Vaccines by: Application (Value)
        • 5.2.2.1. Swine Fever Vaccines
        • 5.2.2.2. Swine Flu Vaccines
        • 5.2.2.3. Porcine Circoviruses
        • 5.2.2.4. Others
      • 5.2.3. Global Porcine Vaccines Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Porcine Vaccines (Volume)
      • 5.3.1. Global Porcine Vaccines by: Type (Volume)
        • 5.3.1.1. Inactivated vaccines
        • 5.3.1.2. Live attenuated vaccines
        • 5.3.1.3. Toxoid vaccines
        • 5.3.1.4. Recombinant vaccines
        • 5.3.1.5. Conjugate vaccines
        • 5.3.1.6. DNA vaccines
      • 5.3.2. Global Porcine Vaccines by: Application (Volume)
        • 5.3.2.1. Swine Fever Vaccines
        • 5.3.2.2. Swine Flu Vaccines
        • 5.3.2.3. Porcine Circoviruses
        • 5.3.2.4. Others
      • 5.3.3. Global Porcine Vaccines Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Porcine Vaccines (Price)
      • 5.4.1. Global Porcine Vaccines by: Type (Price)
  • 6. Porcine Vaccines: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bimeda, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Boehringer Ingelheim International GmbH (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Ceva Sante Animale (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Eli Lilly and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck & Co., Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sanofi S.A. (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Vetoquinol S.A. (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Zoetis, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Porcine Vaccines Sale, by Type, Application and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Porcine Vaccines (Value)
      • 7.2.1. Global Porcine Vaccines by: Type (Value)
        • 7.2.1.1. Inactivated vaccines
        • 7.2.1.2. Live attenuated vaccines
        • 7.2.1.3. Toxoid vaccines
        • 7.2.1.4. Recombinant vaccines
        • 7.2.1.5. Conjugate vaccines
        • 7.2.1.6. DNA vaccines
      • 7.2.2. Global Porcine Vaccines by: Application (Value)
        • 7.2.2.1. Swine Fever Vaccines
        • 7.2.2.2. Swine Flu Vaccines
        • 7.2.2.3. Porcine Circoviruses
        • 7.2.2.4. Others
      • 7.2.3. Global Porcine Vaccines Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Porcine Vaccines (Volume)
      • 7.3.1. Global Porcine Vaccines by: Type (Volume)
        • 7.3.1.1. Inactivated vaccines
        • 7.3.1.2. Live attenuated vaccines
        • 7.3.1.3. Toxoid vaccines
        • 7.3.1.4. Recombinant vaccines
        • 7.3.1.5. Conjugate vaccines
        • 7.3.1.6. DNA vaccines
      • 7.3.2. Global Porcine Vaccines by: Application (Volume)
        • 7.3.2.1. Swine Fever Vaccines
        • 7.3.2.2. Swine Flu Vaccines
        • 7.3.2.3. Porcine Circoviruses
        • 7.3.2.4. Others
      • 7.3.3. Global Porcine Vaccines Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Porcine Vaccines (Price)
      • 7.4.1. Global Porcine Vaccines by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Porcine Vaccines: by Type(USD Million)
  • Table 2. Porcine Vaccines Inactivated vaccines , by Region USD Million (2015-2020)
  • Table 3. Porcine Vaccines Live attenuated vaccines , by Region USD Million (2015-2020)
  • Table 4. Porcine Vaccines Toxoid vaccines , by Region USD Million (2015-2020)
  • Table 5. Porcine Vaccines Recombinant vaccines , by Region USD Million (2015-2020)
  • Table 6. Porcine Vaccines Conjugate vaccines , by Region USD Million (2015-2020)
  • Table 7. Porcine Vaccines DNA vaccines , by Region USD Million (2015-2020)
  • Table 8. Porcine Vaccines: by Application(USD Million)
  • Table 9. Porcine Vaccines Swine Fever Vaccines , by Region USD Million (2015-2020)
  • Table 10. Porcine Vaccines Swine Flu Vaccines , by Region USD Million (2015-2020)
  • Table 11. Porcine Vaccines Porcine Circoviruses , by Region USD Million (2015-2020)
  • Table 12. Porcine Vaccines Others , by Region USD Million (2015-2020)
  • Table 13. South America Porcine Vaccines, by Country USD Million (2015-2020)
  • Table 14. South America Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 15. South America Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 16. Brazil Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 17. Brazil Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 18. Argentina Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 19. Argentina Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 20. Rest of South America Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 21. Rest of South America Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 22. Asia Pacific Porcine Vaccines, by Country USD Million (2015-2020)
  • Table 23. Asia Pacific Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 24. Asia Pacific Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 25. China Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 26. China Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 27. Japan Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 28. Japan Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 29. India Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 30. India Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 31. South Korea Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 32. South Korea Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 33. Taiwan Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 34. Taiwan Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 35. Australia Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 36. Australia Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 37. Rest of Asia-Pacific Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 38. Rest of Asia-Pacific Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 39. Europe Porcine Vaccines, by Country USD Million (2015-2020)
  • Table 40. Europe Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 41. Europe Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 42. Germany Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 43. Germany Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 44. France Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 45. France Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 46. Italy Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 47. Italy Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 48. United Kingdom Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 49. United Kingdom Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 50. Netherlands Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 51. Netherlands Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 52. Rest of Europe Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 53. Rest of Europe Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 54. MEA Porcine Vaccines, by Country USD Million (2015-2020)
  • Table 55. MEA Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 56. MEA Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 57. Middle East Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 58. Middle East Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 59. Africa Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 60. Africa Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 61. North America Porcine Vaccines, by Country USD Million (2015-2020)
  • Table 62. North America Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 63. North America Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 64. United States Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 65. United States Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 66. Canada Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 67. Canada Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 68. Mexico Porcine Vaccines, by Type USD Million (2015-2020)
  • Table 69. Mexico Porcine Vaccines, by Application USD Million (2015-2020)
  • Table 70. Porcine Vaccines Sales: by Type(K Unit)
  • Table 71. Porcine Vaccines Sales Inactivated vaccines , by Region K Unit (2015-2020)
  • Table 72. Porcine Vaccines Sales Live attenuated vaccines , by Region K Unit (2015-2020)
  • Table 73. Porcine Vaccines Sales Toxoid vaccines , by Region K Unit (2015-2020)
  • Table 74. Porcine Vaccines Sales Recombinant vaccines , by Region K Unit (2015-2020)
  • Table 75. Porcine Vaccines Sales Conjugate vaccines , by Region K Unit (2015-2020)
  • Table 76. Porcine Vaccines Sales DNA vaccines , by Region K Unit (2015-2020)
  • Table 77. Porcine Vaccines Sales: by Application(K Unit)
  • Table 78. Porcine Vaccines Sales Swine Fever Vaccines , by Region K Unit (2015-2020)
  • Table 79. Porcine Vaccines Sales Swine Flu Vaccines , by Region K Unit (2015-2020)
  • Table 80. Porcine Vaccines Sales Porcine Circoviruses , by Region K Unit (2015-2020)
  • Table 81. Porcine Vaccines Sales Others , by Region K Unit (2015-2020)
  • Table 82. South America Porcine Vaccines Sales, by Country K Unit (2015-2020)
  • Table 83. South America Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 84. South America Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 85. Brazil Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 86. Brazil Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 87. Argentina Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 88. Argentina Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 89. Rest of South America Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 90. Rest of South America Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 91. Asia Pacific Porcine Vaccines Sales, by Country K Unit (2015-2020)
  • Table 92. Asia Pacific Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 93. Asia Pacific Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 94. China Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 95. China Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 96. Japan Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 97. Japan Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 98. India Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 99. India Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 100. South Korea Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 101. South Korea Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 102. Taiwan Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 103. Taiwan Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 104. Australia Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 105. Australia Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 106. Rest of Asia-Pacific Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 107. Rest of Asia-Pacific Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 108. Europe Porcine Vaccines Sales, by Country K Unit (2015-2020)
  • Table 109. Europe Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 110. Europe Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 111. Germany Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 112. Germany Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 113. France Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 114. France Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 115. Italy Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 116. Italy Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 117. United Kingdom Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 118. United Kingdom Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 119. Netherlands Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 120. Netherlands Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 121. Rest of Europe Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 122. Rest of Europe Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 123. MEA Porcine Vaccines Sales, by Country K Unit (2015-2020)
  • Table 124. MEA Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 125. MEA Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 126. Middle East Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 127. Middle East Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 128. Africa Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 129. Africa Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 130. North America Porcine Vaccines Sales, by Country K Unit (2015-2020)
  • Table 131. North America Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 132. North America Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 133. United States Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 134. United States Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 135. Canada Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 136. Canada Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 137. Mexico Porcine Vaccines Sales, by Type K Unit (2015-2020)
  • Table 138. Mexico Porcine Vaccines Sales, by Application K Unit (2015-2020)
  • Table 139. Porcine Vaccines: by Type(USD/Units)
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Porcine Vaccines: by Type(USD Million)
  • Table 150. Porcine Vaccines Inactivated vaccines , by Region USD Million (2021-2026)
  • Table 151. Porcine Vaccines Live attenuated vaccines , by Region USD Million (2021-2026)
  • Table 152. Porcine Vaccines Toxoid vaccines , by Region USD Million (2021-2026)
  • Table 153. Porcine Vaccines Recombinant vaccines , by Region USD Million (2021-2026)
  • Table 154. Porcine Vaccines Conjugate vaccines , by Region USD Million (2021-2026)
  • Table 155. Porcine Vaccines DNA vaccines , by Region USD Million (2021-2026)
  • Table 156. Porcine Vaccines: by Application(USD Million)
  • Table 157. Porcine Vaccines Swine Fever Vaccines , by Region USD Million (2021-2026)
  • Table 158. Porcine Vaccines Swine Flu Vaccines , by Region USD Million (2021-2026)
  • Table 159. Porcine Vaccines Porcine Circoviruses , by Region USD Million (2021-2026)
  • Table 160. Porcine Vaccines Others , by Region USD Million (2021-2026)
  • Table 161. South America Porcine Vaccines, by Country USD Million (2021-2026)
  • Table 162. South America Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 163. South America Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 164. Brazil Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 165. Brazil Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 166. Argentina Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 167. Argentina Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 168. Rest of South America Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 169. Rest of South America Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 170. Asia Pacific Porcine Vaccines, by Country USD Million (2021-2026)
  • Table 171. Asia Pacific Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 172. Asia Pacific Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 173. China Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 174. China Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 175. Japan Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 176. Japan Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 177. India Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 178. India Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 179. South Korea Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 180. South Korea Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 181. Taiwan Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 182. Taiwan Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 183. Australia Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 184. Australia Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 185. Rest of Asia-Pacific Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 186. Rest of Asia-Pacific Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 187. Europe Porcine Vaccines, by Country USD Million (2021-2026)
  • Table 188. Europe Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 189. Europe Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 190. Germany Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 191. Germany Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 192. France Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 193. France Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 194. Italy Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 195. Italy Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 196. United Kingdom Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 197. United Kingdom Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 198. Netherlands Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 199. Netherlands Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 200. Rest of Europe Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 201. Rest of Europe Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 202. MEA Porcine Vaccines, by Country USD Million (2021-2026)
  • Table 203. MEA Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 204. MEA Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 205. Middle East Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 206. Middle East Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 207. Africa Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 208. Africa Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 209. North America Porcine Vaccines, by Country USD Million (2021-2026)
  • Table 210. North America Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 211. North America Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 212. United States Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 213. United States Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 214. Canada Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 215. Canada Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 216. Mexico Porcine Vaccines, by Type USD Million (2021-2026)
  • Table 217. Mexico Porcine Vaccines, by Application USD Million (2021-2026)
  • Table 218. Porcine Vaccines Sales: by Type(K Unit)
  • Table 219. Porcine Vaccines Sales Inactivated vaccines , by Region K Unit (2021-2026)
  • Table 220. Porcine Vaccines Sales Live attenuated vaccines , by Region K Unit (2021-2026)
  • Table 221. Porcine Vaccines Sales Toxoid vaccines , by Region K Unit (2021-2026)
  • Table 222. Porcine Vaccines Sales Recombinant vaccines , by Region K Unit (2021-2026)
  • Table 223. Porcine Vaccines Sales Conjugate vaccines , by Region K Unit (2021-2026)
  • Table 224. Porcine Vaccines Sales DNA vaccines , by Region K Unit (2021-2026)
  • Table 225. Porcine Vaccines Sales: by Application(K Unit)
  • Table 226. Porcine Vaccines Sales Swine Fever Vaccines , by Region K Unit (2021-2026)
  • Table 227. Porcine Vaccines Sales Swine Flu Vaccines , by Region K Unit (2021-2026)
  • Table 228. Porcine Vaccines Sales Porcine Circoviruses , by Region K Unit (2021-2026)
  • Table 229. Porcine Vaccines Sales Others , by Region K Unit (2021-2026)
  • Table 230. South America Porcine Vaccines Sales, by Country K Unit (2021-2026)
  • Table 231. South America Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 232. South America Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 233. Brazil Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 234. Brazil Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 235. Argentina Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 236. Argentina Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 237. Rest of South America Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 238. Rest of South America Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 239. Asia Pacific Porcine Vaccines Sales, by Country K Unit (2021-2026)
  • Table 240. Asia Pacific Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 241. Asia Pacific Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 242. China Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 243. China Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 244. Japan Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 245. Japan Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 246. India Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 247. India Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 248. South Korea Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 249. South Korea Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 250. Taiwan Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 251. Taiwan Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 252. Australia Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 253. Australia Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 254. Rest of Asia-Pacific Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 255. Rest of Asia-Pacific Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 256. Europe Porcine Vaccines Sales, by Country K Unit (2021-2026)
  • Table 257. Europe Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 258. Europe Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 259. Germany Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 260. Germany Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 261. France Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 262. France Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 263. Italy Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 264. Italy Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 265. United Kingdom Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 266. United Kingdom Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 267. Netherlands Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 268. Netherlands Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 269. Rest of Europe Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 270. Rest of Europe Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 271. MEA Porcine Vaccines Sales, by Country K Unit (2021-2026)
  • Table 272. MEA Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 273. MEA Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 274. Middle East Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 275. Middle East Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 276. Africa Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 277. Africa Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 278. North America Porcine Vaccines Sales, by Country K Unit (2021-2026)
  • Table 279. North America Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 280. North America Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 281. United States Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 282. United States Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 283. Canada Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 284. Canada Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 285. Mexico Porcine Vaccines Sales, by Type K Unit (2021-2026)
  • Table 286. Mexico Porcine Vaccines Sales, by Application K Unit (2021-2026)
  • Table 287. Porcine Vaccines: by Type(USD/Units)
  • Table 288. Research Programs/Design for This Report
  • Table 289. Key Data Information from Secondary Sources
  • Table 290. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Porcine Vaccines: by Type USD Million (2015-2020)
  • Figure 5. Global Porcine Vaccines: by Application USD Million (2015-2020)
  • Figure 6. South America Porcine Vaccines Share (%), by Country
  • Figure 7. Asia Pacific Porcine Vaccines Share (%), by Country
  • Figure 8. Europe Porcine Vaccines Share (%), by Country
  • Figure 9. MEA Porcine Vaccines Share (%), by Country
  • Figure 10. North America Porcine Vaccines Share (%), by Country
  • Figure 11. Global Porcine Vaccines: by Type K Unit (2015-2020)
  • Figure 12. Global Porcine Vaccines: by Application K Unit (2015-2020)
  • Figure 13. South America Porcine Vaccines Share (%), by Country
  • Figure 14. Asia Pacific Porcine Vaccines Share (%), by Country
  • Figure 15. Europe Porcine Vaccines Share (%), by Country
  • Figure 16. MEA Porcine Vaccines Share (%), by Country
  • Figure 17. North America Porcine Vaccines Share (%), by Country
  • Figure 18. Global Porcine Vaccines: by Type USD/Units (2015-2020)
  • Figure 19. Global Porcine Vaccines share by Players 2020 (%)
  • Figure 20. Global Porcine Vaccines share by Players (Top 3) 2020(%)
  • Figure 21. Global Porcine Vaccines share by Players (Top 5) 2020(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 25. Bimeda, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Bimeda, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Boehringer Ingelheim International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Boehringer Ingelheim International GmbH (Germany) Revenue: by Geography 2020
  • Figure 29. Ceva Sante Animale (France) Revenue, Net Income and Gross profit
  • Figure 30. Ceva Sante Animale (France) Revenue: by Geography 2020
  • Figure 31. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 32. Eli Lilly and Company (United States) Revenue: by Geography 2020
  • Figure 33. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Merck & Co., Inc. (United States) Revenue: by Geography 2020
  • Figure 35. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 36. Sanofi S.A. (France) Revenue: by Geography 2020
  • Figure 37. Vetoquinol S.A. (France) Revenue, Net Income and Gross profit
  • Figure 38. Vetoquinol S.A. (France) Revenue: by Geography 2020
  • Figure 39. Zoetis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Zoetis, Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Global Porcine Vaccines: by Type USD Million (2021-2026)
  • Figure 42. Global Porcine Vaccines: by Application USD Million (2021-2026)
  • Figure 43. South America Porcine Vaccines Share (%), by Country
  • Figure 44. Asia Pacific Porcine Vaccines Share (%), by Country
  • Figure 45. Europe Porcine Vaccines Share (%), by Country
  • Figure 46. MEA Porcine Vaccines Share (%), by Country
  • Figure 47. North America Porcine Vaccines Share (%), by Country
  • Figure 48. Global Porcine Vaccines: by Type K Unit (2021-2026)
  • Figure 49. Global Porcine Vaccines: by Application K Unit (2021-2026)
  • Figure 50. South America Porcine Vaccines Share (%), by Country
  • Figure 51. Asia Pacific Porcine Vaccines Share (%), by Country
  • Figure 52. Europe Porcine Vaccines Share (%), by Country
  • Figure 53. MEA Porcine Vaccines Share (%), by Country
  • Figure 54. North America Porcine Vaccines Share (%), by Country
  • Figure 55. Global Porcine Vaccines: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Bayer AG (Germany)
  • Bimeda, Inc. (United States)
  • Boehringer Ingelheim International GmbH (Germany)
  • Ceva Sante Animale (France)
  • Eli Lilly and Company (United States)
  • Merck & Co., Inc. (United States)
  • Sanofi S.A. (France)
  • Vetoquinol S.A. (France)
  • Zoetis, Inc. (United States)
Additional players considered in the study are as follows:
PBS Animal Health (United States) , Aptimmune (United States)
Select User Access Type

Key Highlights of Report


Jan 2021 237 Pages 76 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Porcine Vaccines Quantitative research analysis
Global Porcine Vaccines Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Porcine Vaccines Report?

Have a Query? Click Here

Other Related Reports

Endocrinology Drugs Comprehensive Study by Type (Diabetic Aagents, Hormone Agonists, Hormone Antagonists), Drug (Prescription Drugs, Over-the-counter Drugs), End User (Hospitals, Commercial Laborator...
$ 3350
Cancer Supportive Care Products Comprehensive Study by Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Others), Distrib...
$ 3750
Bulk Drug Comprehensive Study by Type (Branded Prescription Drugs, Over-The-Counter Drugs, Generic Prescription Drugs), Application (Pharmaceutical, Healthcare), Processing Stages (Primary Processing...
$ 3750
Hemorrhagic Septicemia Vaccines Comprehensive Study by Type (Oil - Adjuvant, Aluminium Hydroxide- Adjuvant), Application (Cattle, Buffaloes), End User (Veterinary Hospitals, Veterinary Clinics, Anima...
$ 3500
Immunosuppressant Drugs Comprehensive Study by End-users (Hospitals, Clinics, Others), Indication (Organ Transplantation, Autoimmune Disorders, Non-autoimmune Inflammatory Diseases), Distribution Cha...
$ 3750
Rupatadine Comprehensive Study by Type (150 mg Tablets, 300 mg Tablets, Others), Application (Allergic Rhinitis, Urticaria), Dosage (Tablets, Capsules, Syrup), End User (Hospitals, Clinics) Players a...
$ 3500